| Study | Reason for exclusion |
|---|---|
| Alzoughool 2020 | Review |
| Barone 2020 | Review |
| Bloch 2020 | Review |
| Brasil Ministerio 2020 | Standard operating procedure |
| Budhai 2020 | Feasibility of plasma collection only |
| Cao 2020a | Ineligible intervention |
| Cao 2020b | Review |
| Casadevall 2020a | Review |
| Casadevall 2020b | Editorial |
| Chen 2020a | Review |
| Chen 2020b | Ineligible intervention |
| Chen 2020c | Ineligible intervention |
| ChiCTR2000030312 | Study cancelled before starting recruitment |
| ChiCTR2000030381 | Study cancelled before starting recruitment |
| ChiCTR2000030442 | Study cancelled before starting recruitment |
| Datta 2020 | Review |
| de Assis 2020 | Ineligible indication |
| Dzik 2020 | Review |
| Díez 2020 | Ineligible intervention |
| Fleming 2020 | Letter |
| Franchini 2020 | Standard operating procedure |
| Hammarström 2020 | Review |
| Hu 2020 | Ineligible intervention |
| ISRCTN86534580 | Ineligible intervention |
| Jawhara 2020 | Review |
| Jiang 2020 | Ineligible intervention |
| Kesici 2020 | Letter |
| Khanna 2020 | Review |
| Knudson 2020 | Letter |
| Kominers 2020 | Review |
| Kumar 2020 | Review |
| Lancet Haematology 2020 | Editorial |
| Lanza 2020 | Letter |
| Lin 2020 | Ineligible intervention |
| Ministerio de Salud 2020 | Standard operating procedure |
| NCT04261426 | Ineligible intervention |
| NCT04323800 | Ineligible participant population (participants exposed to COVID‐19) |
| NCT04325672 | Study cancelled before starting recruitment |
| NCT04344015 | Feasibility of plasma collection only |
| NCT04344379 | Ineligible intervention |
| NCT04344977 | Feasibility of plasma collection only |
| NCT04350580 | Ineligible intervention |
| NCT04360278 | Feasibility of plasma collection only |
| NCT04368013 | Ineligible intervention |
| Pawar 2020 | Review |
| Qiu 2020 | No use of convalescent plasma. Reporting on generalised collection of information about Covid‐19 infection relating to aetiology, pathology, symptoms, clinical presentation and some generalised pharmacological treatment methods. The papers do not contain patient data that we required. Article translated by Rujan Shrestha and Ya‐Ying Wang via Cochrane TaskExchange |
| Roback 2020 | Review |
| Robbiani 2020 | Ineligible intervention |
| Rubin 2020 | Review |
| Seghatchian 2020 | Review |
| Sheridan 2020 | Review |
| Shi 2020 | Ineligible intervention |
| Syal 2020 | Review |
| Tanne 2020 | Review |
| Tiberghien 2020 | Review |
| Tu 2020 | No use of convalescent plasma. Reporting on generalised collection of information about Covid‐19 infection relating to aetiology, pathology, symptoms, clinical presentation and some generalised pharmacological treatment methods. The papers do not contain patient data that we required. Article translated by Rujan Shrestha and Ya‐Ying Wang via Cochrane TaskExchange |
| Wong 2020 | Review |
| Xie 2020 | Ineligible intervention |
| Yoo 2020 | Review |
| Zeng 2020a | Letter |
| Zhao 2020b | Review |
| Zhu 2020 | Letter |